(en) TO THE EDITOR : In the review article by Diehl and Day (Nov. 23 issue),1 about the cause, pathogenesis, and treatment of nonalcoholic steatohepatitis, the authors did not mention liraglutide (a glucagon-like peptide 1 analogue) as a therapy in Table 2. [...]
Yildiz, H. (2018). Nonalcoholic Steatohepatitis. The New England journal of medicine, 378(8), 779-780. https://doi.org/10.1056/NEJMc1716786 (Original work published 2018)